This annual ACT course provides basic training in general toxicology. Participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation with a focus on pharmaceutical development. The course includes a mix of lectures with breakout group discussions of regulatory case studies and hands-on analyses of nonclinical data, to give participants the opportunity to apply the concepts of toxicology in the context of drug development. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology.
🗓️ The course is scheduled for April 20–24, 2026.